158 related articles for article (PubMed ID: 30076960)
21. Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.
Li C; Cao J; Zhang N; Tu M; Xu F; Wei S; Chen X; Xu Y
Sci Rep; 2018 Sep; 8(1):14244. PubMed ID: 30250044
[TBL] [Abstract][Full Text] [Related]
22. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
23. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
24. Delivery of the Porcupine Inhibitor WNT974 in Mice.
Zhang LS; Lum L
Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157
[TBL] [Abstract][Full Text] [Related]
25. Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.
Gitau SC; Li X; Zhao D; Guo Z; Liang H; Qian M; Lv L; Li T; Xu B; Wang Z; Zhang Y; Xu C; Lu Y; Du Z; Shan H; Yang B
Front Med; 2015 Dec; 9(4):444-56. PubMed ID: 26626190
[TBL] [Abstract][Full Text] [Related]
26. The Delivery of a Wnt Pathway Inhibitor Toward CSCs Requires Stable Liposome Encapsulation and Delayed Drug Release in Tumor Tissues.
Li C; Liang Y; Cao J; Zhang N; Wei X; Tu M; Xu F; Xu Y
Mol Ther; 2019 Sep; 27(9):1558-1567. PubMed ID: 31350188
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Feng J; Chen HW; Pi LJ; Wang J; Zhan DQ
Oncotarget; 2017 Feb; 8(6):10161-10170. PubMed ID: 28053285
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
[TBL] [Abstract][Full Text] [Related]
29. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
[TBL] [Abstract][Full Text] [Related]
30. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
31. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
32. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
34. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
[TBL] [Abstract][Full Text] [Related]
35. Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.
Yu Y; Hu Z; Li B; Wang Z; Chen S
Mol Cell Biochem; 2019 Jan; 450(1-2):25-34. PubMed ID: 29790114
[TBL] [Abstract][Full Text] [Related]
36. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
37. Dapper-1 induces myocardial remodeling through activation of canonical Wnt signaling in cardiomyocytes.
Hagenmueller M; Riffel JH; Bernhold E; Fan J; Zhang M; Ochs M; Steinbeisser H; Katus HA; Hardt SE
Hypertension; 2013 Jun; 61(6):1177-83. PubMed ID: 23509077
[TBL] [Abstract][Full Text] [Related]
38. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
[TBL] [Abstract][Full Text] [Related]
39. Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.
Dawson K; Aflaki M; Nattel S
J Physiol; 2013 Mar; 591(6):1409-32. PubMed ID: 23207593
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
Goldsberry WN; Meza-Perez S; Londoño AI; Katre AA; Mott BT; Roane BM; Goel N; Wall JA; Cooper SJ; Norian LA; Randall TD; Birrer MJ; Arend RC
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32213921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
